Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33.2M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+534K
-
Total reported value, excl. options
-
$182M
-
Value change
-
+$1.95M
-
Number of buys
-
19
-
Number of sells
-
-15
-
Price
-
$10.08
Significant Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q4 2021
45 filings reported holding NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share as of Q4 2021.
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 33.2M outstanding shares and own 54.2% of the company stock.
Largest 10 shareholders include KCK LTD. (5.62M shares), ORBIMED ADVISORS LLC (4.01M shares), Soleus Capital Management, L.P. (2.31M shares), FMR LLC (1.07M shares), Revelation Capital Management, LLC (667K shares), PICTET ASSET MANAGEMENT SA (560K shares), AMERICAN CENTURY COMPANIES INC (535K shares), Bellevue Group AG (508K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (436K shares), and LORD, ABBETT & CO. LLC (356K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.